Goldman Sachs’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-56
| Closed | -$16K | – | 5959 |
|
|
2022
Q1 | $16K | Buy |
+56
| New | +$16K | ﹤0.01% | 5638 |
|
|
2021
Q2 | – | Sell |
-143
| Closed | -$170K | – | 5685 |
|
|
2021
Q1 | $170K | Buy |
143
+101
| +240% | +$120K | ﹤0.01% | 4891 |
|
|
2020
Q4 | $55K | Buy |
+42
| New | +$55K | ﹤0.01% | 4550 |
|
|
2020
Q3 | – | Sell |
-256
| Closed | -$576K | – | 4618 |
|
|
2020
Q2 | $576K | Buy |
+256
| New | +$576K | ﹤0.01% | 3525 |
|